Risultati per pharmablock
Di seguito l'elenco dei risultati di ricerca trovati rilevanti per la keyword 'pharmablock':
Risultati maggiormente rilevanti:
welcome_pharmablock
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products and services throughout the pharmaceutical R&D process and commercial production. Its core businesses include: a rationally designed building blocks collection, supplying from discovery, to development and commercial; building blocks driven libraries for drug discovery; development and ...
pharmablock productPharmaBlock (USA), Inc. Headquarter： 777 Schwab Rd, Unit D Hatfield, PA 19440, USA; California office： 725 San Aleso Ave, Suite 1 Sunnyvale, CA 94085, USA
building blocks_pharmablockPharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products and services throughout the pharmaceutical R&D process and commercial production. Its core businesses include: a rationally designed building blocks collection, supplying from discovery, to development and commercial; building blocks driven libraries for drug discovery; development and ...
Altri risultati:
pharmablockPharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award. This article was originally published in PR Newswire website.. Related Links: Awards » ACS GCI Pharmaceutical Roundtable Portal (acsgcipr.org) PharmaBlock (Stock code: 300725.SZSE), a global, fully integrated CDMO company focusing on innovative chemistry and low-carbon manufacturing, announced today that it has been ...
pharmablockPharmaBlock has been investing in multiple fronts to improve the business sustainability of the company and the industry. Let's take a look at the practices and experiences that PharmaBlock shared in the book. For more information, please read the eBook presented by DCAT： PharmaBlock's Sustainability Journey: Innovating for a Better Future
pharmablockPharmaBlock Opens New R&D Facility in Pennsylvania —— Expanding Capacity to Deliver GMP Projects. This article was originally published via PR Newswire.. PharmaBlock (stock code: 300725.SZSE), a global, fully integrated CDMO company focused on innovative chemistry and low-carbon manufacturing, announces the opening of its new R&D facility in West Chester, Pennsylvania.
pharmablockOn August 27, 2022, PharmaBlock (300725. SZSE), a global, fully integrated pharmaceutical CDMO focused on innovative chemistry and low carbon manufacturing, announced the official opening of GMP Workshop 502 (W502) at PharmaBlock Zhejiang. W502 is specially equipped with micro-channel and continuous tubular reactors, which will effectively ...